Sharemaestro Newsreel

Cardinal Health Stock Hits a Record High After Earnings: Is CAH Still a Buy?

Cardinal Health CAH gave investors plenty to like in its fiscal fourth-quarter report this week, sending shares to a record high of $258 as Wall Street digests another earnings beat and an encouraging fiscal 2027 outlook. The Dividend Aristocrat's quarterly sales came in below …

If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today

Cencora (NYSE: COR) has significantly outperformed the market over the last decade, with an average annual return of 19.83%. An initial investment of $1000 in COR stock ten years ago would now be worth $6,070.40, highlighting the power of compounded returns. The company currently …

Wellington Group (CAH) discloses 6.34% beneficial stake in Cardinal Health

Wellington Management Group LLP and its affiliated entities have disclosed a 6.34% beneficial ownership stake in Cardinal Health, Inc. (CAH) as of June 30, 2026. This ownership, totaling 14,860,271 shares, is primarily held on behalf of various advisory clients, explaining the shared voting and …

Cardinal Health Stock Loses $912 Million as Recall Searches Test a $63.7 Billion Quarter

Cardinal Health sees more runway in fragmented at-home medical supplies market

Cardinal Health's acquisitions of Strive Medical and AdaptHealth's diabetes business are projected to add two percentage points of growth to its Other segment in fiscal year 2027, strengthening its position in the at-home medical supplies and diabetes markets. CEO Jason Hollar highlighted the fragmented …

Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs

Revvity, Inc. RVTY recently announced the launch of the SuperFlex prenatal screening system, a compact, CE-IVDR-certified automated immunoassay instrument designed to expand access to prenatal and preeclampsia testing. Purpose-built for small to mid-sized laboratories and clinics, the platform is intended to bring reliable, rapid …

Cardinal Health: Q4 Presents Positive Signal For The Company's Long-Term Growth (NYSE:CAH)

Can BWX Technologies' Nuclear Medicine Expansion Boost Growth?

BWX Technologies, Inc. BWXT is broadening its commercial nuclear portfolio through expanded capabilities in nuclear medicine and medical radioisotopes. The company's acquisition of Kinectrics in May 2025 added capabilities in the production and supply of isotopes for the radiopharmaceutical industry, enabling BWXT to expand …

Here's Why You Should Add Cooper Companies Stock to Your Portfolio Now

The Cooper Companies, Inc.'s COO growth is fueled by CooperVision's premium lens migration and MiSight's myopia-management leadership, supported by CooperSurgical's women's health and fertility portfolio. However, channel volatility, private-label transition risks, Asia-Pacific softness and tariff/FX pressures weigh on near-term performance. Long-term opportunities remain strong, …

JPMorgan Adjusts Cardinal Health Price Target to $260 From $215, Maintains Neutral Rating

JPMorgan has raised its price target for Cardinal Health (CAH) to $260 from $215, while maintaining a Neutral rating on the stock. This adjustment comes amidst several other analyst updates for Cardinal Health, with firms like Evercore ISI, TD Cowen, and Deutsche Bank also …

Evercore ISI Adjusts Cardinal Health PT to $270 From $265, Maintains Outperform Rating

Evercore ISI has raised its price target for Cardinal Health (CAH) to $270 from $265, while reiterating an Outperform rating on the stock. This adjustment reflects a continued positive outlook from the analyst firm on the pharmaceutical distributor. The news highlights recent analyst activity …

Deutsche Bank Adjusts Cardinal Health Price Target to $261 From $223, Maintains Hold Rating

Deutsche Bank has updated its price target for Cardinal Health (CAH), increasing it to $261 from the previous $223, while keeping a "Hold" rating on the stock. This adjustment reflects new analyst valuations for the pharmaceutical distributor. The article also lists other recent analyst …

Cencora: Walgreens Volume Disruption Raises New Concern, but We Make No Changes for Now

Cencora disclosed that a portion of the volume it serviced for Walgreens began moving elsewhere starting July 1, causing a 4% drop in shares. Despite this new concern, the company reaffirmed its full-year EPS guidance of $17.75-$17.95, and Morningstar analysts are not yet making …

Insight Wealth Strategies LLC Trims Holdings in McKesson Corporation $MCK

Insight Wealth Strategies LLC significantly reduced its stake in McKesson Corporation by 93.5% in the second quarter. This move comes as McKesson reported strong quarterly earnings, beating expectations with EPS of $9.93 and revenue of $105.38 billion, and raised its quarterly dividend to $0.94 …

Inovio (INO) Q2 2026 Earnings Call Transcript

Inovio (INO) discussed its Q2 2026 financial results and provided an update on its lead candidate, INO-3107, which has a PDUFA date of October 30, 2026. The company highlighted progress in regulatory reviews, commercial launch preparations, and positive Phase III results for VGX-3100 from …

Cardinal Health Inc. stock underperforms Wednesday when compared to competitors

Cardinal Health Inc. (CAH) stock declined by 2.54% on Wednesday, closing at $234.16. This underperformance occurred on a mixed trading day where the S&P 500 Index rose, and the Dow Jones Industrial Average slightly fell. The stock's drop ended a two-day winning streak.

McKesson Corp. stock underperforms Wednesday when compared to competitors

McKesson Corp. (MCK) shares fell by 2.55% on Wednesday, closing at $878.73. This underperformance occurred on a mixed trading day where the S&P 500 Index rose by 0.26% and the Dow Jones Industrial Average declined by 0.04%. The stock's drop ended a two-day winning …

Cencora Inc. stock underperforms Wednesday when compared to competitors

Cencora Inc. (COR) stock fell by 5.90% to $314.17 on Wednesday, underperforming the broader market. This drop occurred despite the S&P 500 Index seeing a slight gain, while the Dow Jones Industrial Average experienced a marginal decline. The stock's fall ended a two-day winning …

Cencora Inc Stock (COR) Closed Down by 5.92% on Aug 12: Key Drivers Unveiled

Cencora Inc (COR) stock closed down by 5.92% on August 12, primarily due to the confirmed transition of non-prime Walgreens pharmaceutical volume to competitors. Despite management reiterating full-year earnings per share guidance, investors focused on potential revenue risks and customer retention challenges in the …

US Equity Markets End Mixed Amid Tech Stock Gains, Lower Inflation Data

US equity indexes ended mixed Wednesday amid stock gains by some major technology stocks and a four-month low inflation rate report.* The consumer price index rose 3.4% in July from a year earlier, decelerating from 3.5% in June, according to data from the Bureau …

Cencora reaffirms $17.75-$17.95 FY26 EPS guidance amid Walgreens shift

Cencora confirmed that some Walgreens volume will shift outside its operations starting July 1, 2026, but its primary vendor agreement with Walgreens remains unaffected. The company reiterated its fiscal year 2026 adjusted diluted EPS guidance of $17.75-$17.95, stating that this change was already factored …

Sector Update: Healthcare Stocks Advance Late Afternoon

Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already …

Cardinal Health (CAH) Stock Looks About Right On Earnings But Stretched On Broader Checks

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. After a very strong multi year run, Cardinal Health stock is now being judged by a low overall value score and fresh questions about …

Henry Schein Inc. stock outperforms competitors on strong trading day

Shares of Henry Schein Inc. (HSIC) increased by 1.75% to $90.74 on Wednesday, marking its second consecutive day of gains. This performance occurred during a mixed trading session where the S&P 500 Index rose by 0.26% and the Dow Jones Industrial Average fell by …

Cardinal Health Earnings: Can Perfection Get Priced In Twice?

Cardinal Health (CAH) saw its stock hit a new all-time high despite mixed Q4 fiscal year results, including a revenue miss and a decline in its Global Medical Products and Distribution unit. The company's growth is being driven by its high-margin cell-and-gene-therapy logistics business, …

Cencora Reports Walgreens Volume Transition, Confirms FY2026 Adjusted EPS Forecast

Cencora, Inc. has reported to the SEC that some Walgreens volume began transitioning out of the company on July 1, 2026, a move that was fully anticipated and does not affect their prime vendor agreement with Walgreens. The company reconfirmed its adjusted diluted EPS …

Cencora says certain Walgreens volume moves outside company; reaffirms FY26 adjusted EPS $17.75-$17.95

Cencora announced that certain Walgreens volume began moving outside the company as of July 1, 2026. Despite this change, the prime vendor agreement with Walgreens, which represents the majority of Cencora's Walgreens business, remains unchanged. Cencora reaffirmed its fiscal year 2026 adjusted diluted EPS …

Cencora dips on loss of some Walgreens business (COR:NYSE)

Cencora's shares experienced a decline in afternoon trading after the medical distributor announced the loss of some business operations previously serving the Walgreens pharmacy chain. The company, formerly known as AmerisourceBergen, stated that certain business activities are moving outside their previous arrangement. This development …

Cencora maintains earnings guidance as some Walgreens volume moves away

Cencora (NYSE:COR) announced that some Walgreens volume previously serviced outside of its prime vendor agreement has shifted away, effective July 1. Despite this change, which was anticipated, the company reaffirmed its adjusted diluted earnings per share guidance of $17.75 to $17.95 for fiscal year …

Cencora (COR) Q3 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Senior Vice President, Investor Relations and Enterprise Productivity - Bennett Murphy President and Chief Executive Officer - Robert Mauch Executive Vice President and Chief Financial Officer - Eva …

CAH Q4 Earnings Call Centers on Fiscal 2027 Growth Outlook

Cardinal Health, Inc. CAH used its fourth-quarter fiscal 2026 call to focus on fiscal 2027 profit growth and normalized pharmaceutical demand. Management also emphasized scaling specialty businesses. The company reported fourth-quarter non-GAAP EPS of $2.91, which topped the Zacks Consensus Estimate of $2.42. Revenues …

Keurig Dr Pepper Adds Cardinal Health CFO Aaron Alt to Board

Keurig Dr Pepper has appointed Cardinal Health CFO Aaron Alt to its board of directors, effective August 14, 2026. Alt's extensive experience in finance and corporate transformation, including serving as CFO for three public companies, will be crucial as KDP prepares to separate into …

Keurig Dr Pepper Announces Appointment of New Director to its Board

FRISCO, Texas and BURLINGTON, Mass., Aug. 12, 2026 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today that Aaron Alt has been appointed a director of the Company's Board of Directors, effective August 14, 2026. Alt brings deep expertise in finance, capital allocation …